WO2006023757A3 - Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents - Google Patents
Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents Download PDFInfo
- Publication number
- WO2006023757A3 WO2006023757A3 PCT/US2005/029605 US2005029605W WO2006023757A3 WO 2006023757 A3 WO2006023757 A3 WO 2006023757A3 US 2005029605 W US2005029605 W US 2005029605W WO 2006023757 A3 WO2006023757 A3 WO 2006023757A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sodium channel
- bicyclic
- monocyclic
- blocking agents
- channel blocking
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/28—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/31—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
- C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60281904P | 2004-08-19 | 2004-08-19 | |
US60/602,819 | 2004-08-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006023757A2 WO2006023757A2 (en) | 2006-03-02 |
WO2006023757A3 true WO2006023757A3 (en) | 2006-08-03 |
Family
ID=35968223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/029605 WO2006023757A2 (en) | 2004-08-19 | 2005-08-19 | Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006023757A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
WO2008121859A1 (en) * | 2007-03-30 | 2008-10-09 | Xenon Pharmaceuticals Inc. | Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions |
US8629135B2 (en) | 2008-07-14 | 2014-01-14 | Queen's University At Kingston | Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
AR080055A1 (en) | 2010-02-01 | 2012-03-07 | Novartis Ag | DERIVATIVES OF PIRAZOLO- [5,1-B] -OXAZOL AS ANTAGONISTS OF THE RECEIVERS OF CRF -1 |
JP5748777B2 (en) | 2010-02-02 | 2015-07-15 | ノバルティス アーゲー | Cyclohexylamide derivatives as CRF receptor antagonists |
US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
AU2013255458A1 (en) | 2012-05-03 | 2014-10-09 | Novartis Ag | L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022895A (en) * | 1997-03-14 | 2000-02-08 | Gruenenthal Gmbh | Substituted amino compounds and their use as substances having an analgesic effect |
US6262104B1 (en) * | 1995-09-15 | 2001-07-17 | Smithkline Beecham P.L.C. | Diarylalkenylamine derivatives |
US6545057B2 (en) * | 2000-09-26 | 2003-04-08 | The Brigham And Women's Hospital Inc. | Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
US20030096805A1 (en) * | 2000-09-26 | 2003-05-22 | Wang Ging Kuo | Antidepressants and their analogues as long-acting local anesthetics and analgesics |
-
2005
- 2005-08-19 WO PCT/US2005/029605 patent/WO2006023757A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262104B1 (en) * | 1995-09-15 | 2001-07-17 | Smithkline Beecham P.L.C. | Diarylalkenylamine derivatives |
US6022895A (en) * | 1997-03-14 | 2000-02-08 | Gruenenthal Gmbh | Substituted amino compounds and their use as substances having an analgesic effect |
US6545057B2 (en) * | 2000-09-26 | 2003-04-08 | The Brigham And Women's Hospital Inc. | Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
US20030096805A1 (en) * | 2000-09-26 | 2003-05-22 | Wang Ging Kuo | Antidepressants and their analogues as long-acting local anesthetics and analgesics |
Also Published As
Publication number | Publication date |
---|---|
WO2006023757A2 (en) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006023757A3 (en) | Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents | |
MXPA06009475A (en) | Quinazoline derivatives and therapeutic use thereof. | |
PL1807434T3 (en) | Thienopyridines as allosteric potentiators of the m4 muscarinic receptor | |
IL178648A0 (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
DE60329001D1 (en) | 8-hydroxychinolinderivate | |
WO2002074758A3 (en) | Novel amines as histamine-3 receptor ligands and their therapeutic applications | |
MXPA06001053A (en) | Pyridazinyl- piperazines and their use as histamine h3 receptor ligands. | |
WO2005013914A8 (en) | Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain | |
HK1094421A1 (en) | (S)-2-n-propylamino-5-hydroxytetralin as a d3-agonist | |
WO2010026436A3 (en) | 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders | |
WO2003066604A3 (en) | Novel aryl- and heteroarylpiperazines | |
WO2005046603A3 (en) | Pyridine compounds | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
MXPA05010621A (en) | Substituted pyrimidinones. | |
WO2006052889A3 (en) | Quinolinone-carboxamide compounds | |
GB0112348D0 (en) | Compounds | |
TW200626158A (en) | Naphthaline derivatives | |
WO2007002361A3 (en) | 3-fluoro-piperidine t-type calcium channel antagonists | |
WO2003024928A3 (en) | Novel aminoazetidine, -pyrrolidine and -piperidine derivatives | |
WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
PL1853232T3 (en) | Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them | |
MX2007006357A (en) | Substituted pteridines for treating inflammatory diseases. | |
MY150210A (en) | Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators | |
WO2002018348A3 (en) | Quinazoline derivatives as alpha-1 adrenergic antagonists | |
WO2006029210A3 (en) | Acyclic 1,3-diamines and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |